WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that the Feinstein Institute of Medical Research scientists presented their study of the “Effect of Topical Nanoviricides in a Rabbit Model of EKC” (epidemic kerato-conjunctivitis) at the 42nd annual meeting of the Ocular Microbiology and Immunology Group (OMIG) in Atlanta, Georgia, on Friday, November 7, 2008. The OMIG meeting was held in conjunction with the International Joint Meeting of the American Academy of Ophthalmology (AAO) and the European Society of Ophthalmology (SEO).
